Literature DB >> 25382379

Optimal survival time-related cut-point with censored data.

Xinhua Liu1, Zhezhen Jin.   

Abstract

In biomedical research and practice, continuous biomarkers are often used for diagnosis and prognosis, with a cut-point being established on the measurement to aid binary classification. When survival time is examined for the purposes of disease prognostication and is found to be related to the baseline measure of a biomarker, employing a single cut-point on the biomarker may not be very informative. Using survival time-dependent sensitivity and specificity, we extend a concordance probability-based objective function to select survival time-related cut-points. To estimate the objective function with censored survival data, we adopt a non-parametric procedure for time-dependent receiver operational characteristics curves, which uses nearest neighbor estimation techniques. In a simulation study, the proposed method, when used to select a cut-point to optimally predict survival at a given time within a specified range, yields satisfactory results. We apply the procedure to estimate survival time-dependent cut-point on the prognostic biomarker of serum bilirubin among patients with primary biliary cirrhosis.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  censored data; concordance probability; cut-point; sensitivity; specificity

Mesh:

Substances:

Year:  2014        PMID: 25382379     DOI: 10.1002/sim.6360

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  Optimal cut-point definition in biomarkers: the case of censored failure time outcome.

Authors:  Matteo Rota; Laura Antolini; Maria Grazia Valsecchi
Journal:  BMC Med Res Methodol       Date:  2015-03-21       Impact factor: 4.615

2.  Association between Sarcopenia and Immediate Complications and Mortality in Patients with Oral Cavity Squamous Cell Carcinoma Undergoing Surgery.

Authors:  Chun-Hou Huang; Kun-Han Lue; Peir-Rorg Chen; Tsung-Cheng Hsieh; Yu-Fu Chou
Journal:  Cancers (Basel)       Date:  2022-02-03       Impact factor: 6.639

3.  The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study).

Authors:  Matteo Bauckneht; Sara Elena Rebuzzi; Alessio Signori; Viviana Frantellizzi; Veronica Murianni; Elisa Lodi Rizzini; Manlio Mascia; Valentina Lavelli; Maria Isabella Donegani; Marta Ponzano; Angela Gaudiano; Maria Lina Stazza; Maria Licari; Letizia Cavallini; Viola Laghi; Luca Cindolo; Martina Maggi; Alessandro Sciarra; Paolo Mammucci; Gianmario Sambuceti; Renato Patrizio Costa; Angela Spanu; Giuseppe Rubini; Fabio Monari; Giuseppe De Vincentis; Giuseppe Fornarini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-09-06       Impact factor: 9.236

4.  Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.

Authors:  Marianna Rossi; Manja Meggendorfer; Matteo Zampini; Mauro Tettamanti; Emma Riva; Erica Travaglino; Matteo Bersanelli; Sara Mandelli; Alessia Antonella Galbussera; Ettore Mosca; Elena Saba; Chiara Chiereghin; Nicla Manes; Chiara Milanesi; Marta Ubezio; Lucio Morabito; Clelia Peano; Giulia Soldà; Rosanna Asselta; Stefano Duga; Carlo Selmi; Maria De Santis; Karolina Malik; Giulia Maggioni; Marilena Bicchieri; Alessia Campagna; Cristina A Tentori; Antonio Russo; Efrem Civilini; Paola Allavena; Rocco Piazza; Giovanni Corrao; Claudia Sala; Alberto Termanini; Laura Giordano; Paolo Detoma; Aurelio Malabaila; Luca Sala; Stefano Rosso; Roberto Zanetti; Claudia Saitta; Elena Riva; Gianluigi Condorelli; Francesco Passamonti; Armando Santoro; Francesc Sole; Uwe Platzbecker; Pierre Fenaux; Niccolò Bolli; Gastone Castellani; Wolfgang Kern; George S Vassiliou; Torsten Haferlach; Ugo Lucca; Matteo G Della Porta
Journal:  Blood       Date:  2021-11-25       Impact factor: 22.113

5.  Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).

Authors:  Sara Elena Rebuzzi; Alessio Signori; Giuseppe Luigi Banna; Marco Maruzzo; Ugo De Giorgi; Paolo Pedrazzoli; Andrea Sbrana; Paolo Andrea Zucali; Cristina Masini; Emanuele Naglieri; Giuseppe Procopio; Sara Merler; Laura Tomasello; Lucia Fratino; Cinzia Baldessari; Riccardo Ricotta; Stefano Panni; Veronica Mollica; Maria Sorarù; Matteo Santoni; Alessio Cortellini; Veronica Prati; Hector Josè Soto Parra; Marco Stellato; Francesco Atzori; Sandro Pignata; Carlo Messina; Marco Messina; Franco Morelli; Giuseppe Prati; Franco Nolè; Francesca Vignani; Alessia Cavo; Giandomenico Roviello; Francesco Pierantoni; Chiara Casadei; Melissa Bersanelli; Silvia Chiellino; Federico Paolieri; Matteo Perrino; Matteo Brunelli; Roberto Iacovelli; Camillo Porta; Sebastiano Buti; Giuseppe Fornarini
Journal:  Ther Adv Med Oncol       Date:  2021-05-18       Impact factor: 8.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.